Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:139-140
doi: 10.1161/01.RES.0000156076.17807.1F
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tian, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tian, R.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Cell signalling/signal transduction
Right arrow Type 2 diabetes
Right arrow Glucose intolerance
Right arrow Receptor pharmacology
Right arrowRelated Article
(Circulation Research. 2005;96:139.)
© 2005 American Heart Association, Inc.


Editorials

Another Role for the Celebrity

Akt and Insulin Resistance

Rong Tian

From the NMR Laboratory for Physiological Chemistry, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Rong Tian, MD, PhD, 221 Longwood Ave, Room 252, Boston, MA 02115. E-mail rtian@rics.bwh.harvard.edu

See related article, pages 180–188


Key Words: insulin signaling • Akt • phosphorylation • ß-adrenergic stimulation


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Insulin is the most potent anabolic hormone and is essential for tissue development, growth, and maintenance of whole-body glucose homeostasis. Failure of the target cells to respond to insulin stimulation, ie, insulin resistance, is commonly observed under acute stress conditions and in individuals with obesity, metabolic syndrome, or diabetes. Insulin resistance has been considered a major risk factor for the development and progression of cardiovascular disease.1,2 Although a well-documented phenomenon, the molecular mechanisms leading to insulin resistance remain elusive, attributable, in part, to the complexity of the insulin signaling pathway.

Circulating insulin binds to and activates its cell surface receptor to elicit its biological actions (Figure). The insulin receptor is a widely expressed transmembrane tyrosine kinase consisting of two {alpha}- and two ß-subunits.3,4 The binding of insulin to the extracellular {alpha}-subunit results in a rapid configurational change in the receptor leading to the autophosphorylation of specific tyrosine residues of the intracellular region of the ß-subunit.5 This process results in activation of the tyrosine kinase activity of the insulin receptor, which transmits the insulin signal by phosphorylating a number of substrate proteins.5,6 The insulin-receptor signaling involves two major pathways: the mitogen activated protein kinase (MAPK) pathway, mainly responsible for mitogenesis and cell growth, and the phosphatidylinositol-3-kinase (PI3-K) pathways, mainly account for the metabolic responses (Figure; although depicted as linear pathways, these two systems also interact under certain conditions). A critical player in the PI3-K pathway is the Ser/Thr kinase Akt (PKB), which serves as a multifaceted intermediary . . . [Full Text of this Article]


Related Article:

Akt Mediates the Cross-Talk Between ß-Adrenergic and Insulin Receptors in Neonatal Cardiomyocytes
Carmine Morisco, Gerolama Condorelli, Valentina Trimarco, Alessandro Bellis, Chiara Marrone, Gianluigi Condorelli, Junichi Sadoshima, and Bruno Trimarco
Circ. Res. 2005 96: 180-188. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Virol.Home page
S. Banerjee, K. Saito, M. Ait-Goughoulte, K. Meyer, R. B. Ray, and R. Ray
Hepatitis C Virus Core Protein Upregulates Serine Phosphorylation of Insulin Receptor Substrate-1 and Impairs the Downstream Akt/Protein Kinase B Signaling Pathway for Insulin Resistance
J. Virol., March 15, 2008; 82(6): 2606 - 2612.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
W.-Q. Zhao, F. G. De Felice, S. Fernandez, H. Chen, M. P. Lambert, M. J. Quon, G. A. Krafft, and W. L. Klein
Amyloid beta oligomers induce impairment of neuronal insulin receptors
FASEB J, January 1, 2008; 22(1): 246 - 260.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-Y. Deng, J.-P. Huang, L.-S. Lu, and L.-M. Hung
Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose-fed rats
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H978 - H987.
[Abstract] [Full Text] [PDF]